Physician profile
Joseph C Wehman
NPI 1023141371
$167,292.23
in general payments reported to CMS, 2019-2025
11 companies · $19K in 2025
The $19K reported for 2025 was more than what 89% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $16K · 2021: $29K · 2022: $36K · 2023: $32K · 2024: $36K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $71K · Consulting Fee: $16K · Food and Beverage: $74.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $70,699.09 |
| Consulting Fee | $15,910.70 |
| Food and Beverage | $74.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osseus Fusion Systems, LLC | $135,240.22 | 2020-2024 | |
| Xenix Medical LLC | $19,039.83 | 2019-2025 | Solace |
| Medyssey USA, INC | $11,375.00 | 2024-2025 | |
| Centinel Spine, LLC | $658.64 | 2019-2021 | |
| Ulrich Medical USA, INC. | $567.97 | 2022 | |
| Nanovis LLC | $182.00 | 2021 | |
| Stryker Corporation | $87.00 | 2021-2024 | Universal Neuro 3 |
| Orthofix Medical, INC. | $65.28 | 2019-2023 | Regatta Lateral System |
| Integrity Implants INC. | $44.41 | 2019 | |
| Zavation Medical Products, LLC | $16.97 | 2024 | |
| Innovation Technologies INC | $14.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Wehman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.